🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study compares the efficacy of neoadjuvant low-dose radiotherapy plus ...
Status
Withdrawn
Location
Multiple Locations
Start Date
2025-01-20
Trial ID
NCT06804850
Treatments Being Tested
Up to 38 subjects entered with the aim of entering 8 subjects with mild liv...
Status
Completed
Location
1200.86.1 Boehringer Ingelheim Investigational Site
Start Date
2011-02
Trial ID
NCT01298063
The purpose of this study was to evaluate the safety and tolerability of lo...
Status
Completed
Location
West China Hospital, Sichuan University
Start Date
2024-07-31
Trial ID
NCT06494189
Treatments Being Tested
This is a phase 2 trial investigating the effect and safety of afatinib in ...
Status
Unknown
Location
Peking University Cancer Hospital and Institute
Start Date
2019-04-28
Trial ID
NCT03940976
Treatments Being Tested
Evaluation of the safety and tolerability of immune-targeted therapy combin...
Status
Recruiting
Location
West China Hospital, Sichuan University
Start Date
2024-12-15
Trial ID
NCT06741982
Treatments Being Tested
The objective of the Phase I step is to estimate the MTD at a dose level up...
Status
Completed
Location
1200.33.010 Boehringer Ingelheim Investigational Site
Start Date
2008-04
Trial ID
NCT00711594
Treatments Being Tested
This phase II MATCH screening and multi-sub-trial studies how well treatmen...
Status
Active Not Recruiting
Location
University of Alabama at Birmingham Cancer Center
Start Date
2015-08-17
Trial ID
NCT02465060
Treatments Being Tested
To explore the efficiency and safety of TP chemotherapy, tislelizumab, comb...
Status
Completed
Location
West China Hospital, Sichuan University
Start Date
2022-09-12
Trial ID
NCT05516589
Treatments Being Tested
This phase I trial studies the side effects and best dose of afatinib and n...
Status
Terminated
Location
City of Hope National Medical Center
Start Date
2017-07-20
Trial ID
NCT03054038
Treatments Being Tested
This study is a multi-center, open-label, phase Ib study to evaluate the sa...
Status
Unknown
Location
Beijing Cancer Hospital
Start Date
2021-12-25
Trial ID
NCT05164848